乐普医疗
(300003)
| 流通市值：253.41亿 | | | 总市值：295.87亿 |
| 流通股本：15.79亿 | | | 总股本：18.43亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 4,938,709,224.18 | 3,369,384,556.21 | 1,736,231,253.08 | 6,103,269,105.88 |
| 营业收入 | 4,938,709,224.18 | 3,369,384,556.21 | 1,736,231,253.08 | 6,103,269,105.88 |
| 二、营业总成本 | 3,806,841,489.27 | 2,565,093,395.65 | 1,321,825,918.33 | 5,522,118,442.71 |
| 营业成本 | 1,767,707,481.94 | 1,204,217,388.49 | 624,607,361.27 | 2,387,647,101.63 |
| 税金及附加 | 61,366,083.16 | 43,699,453.96 | 23,165,185.55 | 86,392,279.47 |
| 销售费用 | 820,741,165.11 | 548,512,370.81 | 298,470,737.67 | 1,436,940,700.37 |
| 管理费用 | 473,105,528.22 | 311,690,421.88 | 138,974,325.21 | 799,337,214.54 |
| 研发费用 | 594,211,229.49 | 394,921,539.53 | 203,326,022.08 | 769,557,235.27 |
| 财务费用 | 89,710,001.35 | 62,052,220.98 | 33,282,286.55 | 42,243,911.43 |
| 其中:利息费用 | 133,741,215 | 88,577,130.33 | 44,734,185.01 | 180,999,999.83 |
| 其中:利息收入 | 65,202,772.96 | 42,478,848.04 | 21,802,480.09 | 115,513,065.3 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -3,815,806.49 | -2,291,463.8 | 937,293.8 | 389,477.71 |
| 加:投资收益 | -31,566,578.11 | -7,364,734.27 | 19,648,975.2 | -89,713,050.06 |
| 资产处置收益 | -514,648.24 | -635,110.56 | -385,049.34 | 11,731,723.82 |
| 资产减值损失(新) | -6,973,231.55 | -5,865,343.49 | -2,271,438.27 | -287,867,093.11 |
| 信用减值损失(新) | -22,922,819.43 | -22,482,960.93 | -16,152,446.12 | -56,113,783.9 |
| 其他收益 | 110,375,129.58 | 74,523,497.26 | 52,264,969.51 | 93,561,373.25 |
| 四、营业利润 | 1,176,449,780.67 | 840,175,044.77 | 468,447,639.53 | 253,139,310.88 |
| 加:营业外收入 | 7,557,394.76 | 3,789,501.31 | 2,095,149.76 | 13,225,333.92 |
| 减:营业外支出 | 24,691,915.83 | 14,817,072.87 | 5,637,635.19 | 40,603,998.68 |
| 五、利润总额 | 1,159,315,259.6 | 829,147,473.21 | 464,905,154.1 | 225,760,646.12 |
| 减:所得税费用 | 163,320,989.35 | 129,779,939.02 | 87,691,140.81 | 28,466,779.07 |
| 六、净利润 | 995,994,270.25 | 699,367,534.19 | 377,214,013.29 | 197,293,867.05 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 995,994,270.25 | 699,367,534.19 | 377,214,013.29 | 197,293,867.05 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 982,053,022.16 | 690,925,899.89 | 378,539,846.83 | 246,937,715.5 |
| 少数股东损益 | 13,941,248.09 | 8,441,634.3 | -1,325,833.54 | -49,643,848.45 |
| 扣除非经常损益后的净利润 | 940,907,198.82 | 662,195,779.67 | 337,386,464.42 | 221,430,404.42 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.53 | 0.37 | 0.21 | 0.13 |
| (二)稀释每股收益 | 0.53 | 0.37 | 0.21 | 0.13 |
| 八、其他综合收益 | 161,148,244.62 | 107,289,444.54 | 11,828,838.14 | -60,891,593.56 |
| 归属于母公司股东的其他综合收益 | 163,604,820.13 | 109,359,677.84 | 14,710,016.23 | -38,659,869.39 |
| 九、综合收益总额 | 1,157,142,514.87 | 806,656,978.73 | 389,042,851.43 | 136,402,273.49 |
| 归属于母公司股东的综合收益总额 | 1,145,657,842.29 | 800,285,577.73 | 393,249,863.06 | 208,277,846.11 |
| 归属于少数股东的综合收益总额 | 11,484,672.58 | 6,371,401 | -4,207,011.63 | -71,875,572.62 |
| 公告日期 | 2025-10-25 | 2025-08-23 | 2025-04-19 | 2025-04-19 |
| 审计意见(境内) | | | | 标准无保留意见 |